CAS RN: 103060-53-3 | Product Number: D4229
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Purity / Analysis Method||>94.0%(HPLC)(N)|
|Molecular Formula / Molecular Weight||C__7__2H__1__0__1N__1__7O__2__6 = 1620.69|
|Physical State (20 deg.C)||Solid|
|Condition to Avoid||Heat Sensitive|
|Reaxys Registry Number||8186242|
|PubChem Substance ID||172089104|
|Merck Index (14)||2823|
|Appearance||White to Yellow to Orange powder to crystal|
|Purity(HPLC)||min. 94.0 area%|
|Purity(with Total Nitrogen)||min. 94.0 %|
|Maximum Absorption Wavelength||260(EtOH) nm|
|Solubility in water||Completely soluble|
|Solubility (soluble in)||Methanol|
|Solubility (very slightly)||Ethanol|
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.